Sök artiklar i SveMed+

Tidskrift

Sammanfattning

Background: Acute tryptophan depletion (ATD) is a well-established dietary method in translational brain research used to briefly lower central nervous serotonin (5-hydroxytryptamine (5-HT)) synthesis. A simplified two amino acid ATD formula (ATDPHE/LEU) was developed while reducing the overall amount of amino acids (AAs), with the objective of administration especially in children and adolescents in future studies. Objective: This study investigated tryptophan (TRP) influx rates across the blood-brain barrier (BBB) after dietary ATD PHE/LEU administration relative to the ATD Moja-De protocol that has been established for use in children and adolescents. Design: Seventy-two healthy adults (50% females) were randomized into four groups and administered ATD Moja-De, its TRP-balanced control condition (BAL), ATD PHE/LEU, or its respective control mixture (BAL PHE/LEU) in a counterbalanced, double-blind, between-subjects design. Blood samples were collected at baseline and at hourly intervals for 6 h after AA intake. Questionnaires about mood, taste, and challenge tolerance were completed at fixed time points. Results: Both challenge mixtures significantly reduced central nervous TRP influx as calculated by Michaelis Menten kinetics relative to baseline and the respective control conditions with only mild and comparable side effects. A greater decline in TRP influx over the BBB after ATD PHE/LEU administration when compared with ATD MojaDe was detected without group effects for taste, challenge tolerance, and mood. There was unintended initial short increase in plasma TRP concentrations observed after ATD PHE/LEU intake, and a possible redistribution between free and protein-bound TRP triggered by protein synthesis stimulated by the ingested AAs may account for this finding. Moreover, a decline in TRP influx after BAL PHE/LEU administration over a 6-h periodwas observed, and the large amount of PHE in the BAL PHE/LEU mixture may be a possible explanation for this particular phenomenon, which could have led to an unexpected increase in displacement of TRP at the BBB in this control condition. Conclusions: This pilot study provides preliminary evidence for the possibility of lowering TRP influx as calculated by MichaelisMenten kinetics into the brain by using a simplified ATD protocol in humans. The simplified composition of only two AAs, the lower overall AA amount, and the appropriate tolerance are characteristics of the newly developed ATD PHE/LEU protocol. Future studies focusing on the effects of the ATD PHE/LEU protocol and its respective control condition on CSF 5-HIAA concentrations, as well as neurochemical studies in rodents, are needed to further validate this newly developed AA mixture before definite conclusions about its usability in ATDrelated research in humans, its specificity, and additional effects can be made.

MeSH